If you missed our live session, you can now watch the full replay anytime.
Dr. Vanessa Emslie,
Chief Functional Medicine Officer at Willbe, shared the science behind Hormone Archetypes™, how your genes influence hormonal changes, and how FemGene® — the first genetic test designed specifically for women in perimenopause — can offer clarity and personalized solutions. She also walked through real-life cases of women finding balance and relief through Willbe’s innovative approach, followed by a Q&A where she answered member questions.
CLICK HERE
About Willbe
Willbe is a femtech company redefining perimenopause with gene-based hormone care. FemGene® decodes how each woman is genetically wired to respond to hormonal decline, predicting symptoms and guiding personalized hormone therapy for faster relief and safer, longer-lasting results. Their Hormone Archetype™ methodology gives women clarity, answers, and confidence, transforming perimenopause into a time of empowerment and renewal.
About Dr. Vanessa Emslie
Dr. Vanessa Emslie, Chief Functional Medicine Officer, is pioneering Hormogenomics™ and Hormogenetics™, offering a groundbreaking lens on how declining hormone levels during perimenopause influence gene expression. With a PhD in Longevity and expertise in genetics, hormone science, and functional medicine, she integrates these disciplines into a precision-guided approach to perimenopause. Dr. Emslie is shaping the future of female healthcare while training a new generation of doctors to deliver personalized, preventative, and predictive care. Her work empowers women to decode their unique biological blueprint and transform midlife into a launchpad for long-term vitality and healthspan.
Watch the Replay
The full recording is now available inside B Better. Click the link below to watch! (You can access all replays with a free trial—no credit card needed.)
CLICK HERE TO WATCH THE REPLAY
